28. Deputy Michael Collins asked the Minister for Health the progress which has been made in the negotiations between the HSE and a company (details supplied) to ensure that the 19 patients currently involved in the clinical trials will have unlimited access to the Respreeza treatment for the remainder of their lives; and if the small group affected by alpha 1 here will also have access to Respreeza. [16242/18]

Summary

28. Deputy Michael Collins asked the Minister for Health the progress which has been made in the negotiations between the HSE and a company (details supplied) to ensure that the 19 patients currently involved in the clinical trials will have unlimited access to the Respreeza treatment for the remainder of their lives; and if the small group affected by alpha 1 here will also have access to Respreeza. [16242/18]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 19 April 2018

   Medicinal Products Availability

   28. Deputy Michael Collins asked the Minister for Health the progress which has been made in the negotiations between the HSE and a company (details supplied) to ensure that the 19 patients currently involved in the clinical trials will have unlimited access to the Respreeza treatment for the remainder of their lives; and if the small group affected by alpha 1 here will also have access to Respreeza. [16242/18]

   Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Availability

  xml · EN · 19 April 2018

  ViewDownloadOpen at official source

Sponsors

• Collins, Michael. · Asking member
• Health · Health · Addressed to

Related records

No cross-record relationships stored yet.